These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 30747432)

  • 1. [Vancomycin-resistant enterococci].
    Kolář M
    Klin Mikrobiol Infekc Lek; 2018 Jun; 24(2):50-56. PubMed ID: 30747432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Surveillance of multiresistance: vancomycin-resistant Enterococcus spp.].
    González-Abad MJ; Alonso Sanz M
    An Pediatr (Engl Ed); 2019 Oct; 91(4):267-268. PubMed ID: 30528896
    [No Abstract]   [Full Text] [Related]  

  • 3. Multidrug-resistant enterococci in the hospital environment: detection of novel vancomycin-resistant E. faecium clone ST910.
    Dziri R; Lozano C; Ben Said L; Bellaaj R; Boudabous A; Ben Slama K; Torres C; Klibi N
    J Infect Dev Ctries; 2016 Aug; 10(8):799-806. PubMed ID: 27580324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergence of vancomycin-resistant enterococci in Switzerland: a nation-wide survey.
    Buetti N; Wassilew N; Rion V; Senn L; Gardiol C; Widmer A; Marschall J;
    Antimicrob Resist Infect Control; 2019; 8():16. PubMed ID: 30675343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of Vancomycin-Resistant Enterococcus Strains in the West Balkans: A First Report.
    Jakovac S; Bojić EF; Ibrišimović MA; Tutiš B; Ostojić M; Hukić M
    Microb Drug Resist; 2017 Jan; 23(1):122-126. PubMed ID: 27351410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial resistance profile of Enterococcus species isolated from intestinal tracts of hospitalized patients in Jimma, Ethiopia.
    Abamecha A; Wondafrash B; Abdissa A
    BMC Res Notes; 2015 Jun; 8():213. PubMed ID: 26036911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oritavancin Combinations with β-Lactams against Multidrug-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci.
    Smith JR; Yim J; Raut A; Rybak MJ
    Antimicrob Agents Chemother; 2016 Apr; 60(4):2352-8. PubMed ID: 26833159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vancomycin-resistant enterococci: mechanisms and clinical observations.
    Gold HS
    Clin Infect Dis; 2001 Jul; 33(2):210-9. PubMed ID: 11418881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vancomycin-Resistant Enterococci: Therapeutic Challenges in the 21st Century.
    Miller WR; Murray BE; Rice LB; Arias CA
    Infect Dis Clin North Am; 2016 Jun; 30(2):415-439. PubMed ID: 27208766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A hospital-wide screening programme to control an outbreak of vancomycin-resistant enterococci in a large tertiary hospital in Hong Kong.
    Lai CK; Wong SY; Lee SS; Siu HK; Chiu CY; Tsang DN; Ip MP; Hung CT
    Hong Kong Med J; 2017 Apr; 23(2):140-9. PubMed ID: 28232642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and distribution of VRE (vancomycin resistant enterococci) and VSE (vancomycin susceptible enterococci) strains in the breeding environment.
    Skowron K; Jeleńska A; Paluszak Z; Szala B
    Ann Agric Environ Med; 2016 Jun; 23(2):231-6. PubMed ID: 27294624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are vancomycin-resistant enterococci a problem in Polish hospitals?
    Talaga K; Bulanda M
    Przegl Epidemiol; 2015; 69(4):717-22, 861-4. PubMed ID: 27139350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First outbreak of linezolid-resistant vancomycin-resistant Enterococcus faecium in an Irish hospital, February to September 2014.
    O'Driscoll C; Murphy V; Doyle O; Wrenn C; Flynn A; O'Flaherty N; Fenelon LE; Schaffer K; FitzGerald SF
    J Hosp Infect; 2015 Dec; 91(4):367-70. PubMed ID: 26520594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Daptomycin: A viable therapeutic option for vancomycin-resistant enterococcal urinary-tract infections in Indian medical settings?
    Mohan B; Garg S; Appannanavar SB; Taneja N
    Indian J Med Microbiol; 2016; 34(3):398-9. PubMed ID: 27514977
    [No Abstract]   [Full Text] [Related]  

  • 15. Forthcoming therapeutic perspectives for infections due to multidrug-resistant Gram-positive pathogens.
    Cornaglia G; Rossolini GM
    Clin Microbiol Infect; 2009 Mar; 15(3):218-23. PubMed ID: 19335369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renaissance of vancomycin: approaches for breaking antibiotic resistance in multidrug-resistant bacteria.
    Mühlberg E; Umstätter F; Kleist C; Domhan C; Mier W; Uhl P
    Can J Microbiol; 2020 Jan; 66(1):11-16. PubMed ID: 31545906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multidrug-resistant gram-positive pathogens. An update on current microbiological patterns.
    Marchese A; Debbia EA; Bacca D; Balistreri G; Musolino B; Schito GC
    Drugs; 1997; 54 Suppl 6():11-20. PubMed ID: 9474477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidrug-resistant Enterococcus faecium. An untreatable nosocomial pathogen.
    Spera RV; Farber BF
    Drugs; 1994 Nov; 48(5):678-88. PubMed ID: 7530626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of β-lactam antimicrobial resistance and epidemiology of major community- and healthcare-associated multidrug-resistant bacteria.
    Tang SS; Apisarnthanarak A; Hsu LY
    Adv Drug Deliv Rev; 2014 Nov; 78():3-13. PubMed ID: 25134490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Vancomycin-resistant enterococci - the nature of resistance and risk of transmission from animals to humans].
    Hermanovská L; Bardoň J; Čermák P
    Klin Mikrobiol Infekc Lek; 2016 Jun; 22(2):54-60. PubMed ID: 27450523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.